Dutch Life Sciences Outlook 2014

Commentaren

Transcriptie

Dutch Life Sciences Outlook 2014
Dutch Life Sciences Outlook 2014
-Since 2009-
-The Fifth Edition-
Over the past 5 years, The Decision Group has
monitored the performance and progress of the
Dutch Life Sciences Cluster. The results, based on 6
Key Performance Indicators, are compared to an
international context. The Dutch Life Sciences
Cluster seems to stabilize, although when
depicted against the international average as
well as international top clusters, the growth of
the Dutch cluster is lagging behind. In sum, the
cluster is at a crossroads. Three strategic options
are formulated based on international experts,
cluster theories, extensive research, strategic
reports and input of institutions (CEBR, HBS
Microeconomics of Competitiveness). We would
like to start a dialogue, from a company
perspective, about the future and direction of the
cluster. Join the dialogue!
The Dutch life sciences cluster has stabilized
Total jobs (KPI* 2)
2012
2011
2010
2009
2008
22623
22732
24385
24255
24095
Listed and non-listed companies (KPI 1)
2012
2011
2010
2009
2008
361
344
329
314
298
+ 5%
2012
2011
2010
2009
2008
+ 1%
- 84%
Milestone capital, Venture
capital, IPO’s… in m€ (KPI 6)
2012
2011
2010
2009
2008
Total products (KPI 3)
-0%
+ 7%
304
Total revenue in b€ (KPI 4)
2012
2011
2010
2009
2008
- 14%
1887**
96
95
107
94
82
280
19
17,8
17,7
18,7
18,2
622
167
PPPs*** and subsidies in m€ (KPI 5)
2012
2011
2010
2009
2008
* Key Performance Indicator
** Including the acquisition of Crucell by J&J amounting 1687 m€
*** Public Private Partnerships
250
291
297
248
248
Cluster growth is lagging behind internationally
Growth rate over 2008 - 2012
Progress 2008 - 2012
17%
(CAGR 1%)
Innovation
in
terms of number
of products is
growing slower.
(2008 – 2012)
Dutch cluster
216%
(CAGR 34%)
San Diego Top cluster
International
Average
Revenue (€)
39%
(CAGR 9%)
8
(Boston area)
6
Number of
products (#)
60%
(CAGR 13%)
Input in terms of
private
investments is growing
more slowly.
(2008 – 2012)
(Medicon Valley)
4
Employment
(#)
2
(Medicon Valley)
(UK)
Dutch cluster
UK Top cluster
Number of
companies (#)
10
(UK)
996%
(CAGR 82%)
Private
investmens
raised (€)
Public investments
(€)
(RTP area)
International
Average
161%
(CAGR 33%)
World Competitiveness Index
5th
Declining
Competitiveness
8th
2011
2012
(2011 – 2012)
What are the Strategic Options?
Managing the uncertainties
Recovery
after
down-sizing of
large companies.
Increased
national
financial stability.
Fragmented
hub
approach
Risk of running out of steam
1
57%
more employees
22%
15%
more revenue
more companies
(2011-2012)
Create a cluster
based on smart
Involve identifying competitive advantages
specialization
2
SMEs*
are
growing (employment,
companies and revenue)
(2008-2012)
* Small and Medium Enterprises
Mobilize
stakeholders
and resources
Smart specialization
Deliver smart, sustainable and
inclusive growth
Align assets
Excellencedriven vision
Next generation
(Public)
investments are
paying off.
Convergence &
Co-creation between
clusters
3
The cluster is at a crossroads
- Download the Dutch Life Sciences Outlook now from www.lifesciencesoutlook.com -
Several actors are acting on
clusters and influencing its
performance. Between the
actors and the firms, bridges are
formed by cluster organizations.
Dutch Life Sciences Cluster
A cluster is defined by Prof.
Michael Porter as “a geographic
concentration of interconnected
companies, specialized suppliers,
service providers, related
industries, and associated
institutions in particular fields,
that compete and also
cooperate“.
From: Clusnet report (2011)
From: Clusters and your economy,
University of Southern Denmark
What is a cluster?
Adapted From: Life Sciences & Health
The Netherlands Center for Competitiveness
With help from our academic colleagues, the Netherlands Center for Competitiveness has
been founded. It is the logical consequence of our past experiences. The center combines the
international network of cluster organizations with academic and pragmatic expertise on
international business. We call this combination of an academic and pragmatic approach:
the pracademic approach. The aim of the Netherlands Center for Competitiveness
is to provide expertise, access and knowledge to companies that wish to build their international business and academic
institutes that wish to increase their knowledge. Visit www.centerforcompetitiveness.nl for more information.
The Decision Group anually studies the position of the Duch life sciences & health cluster in comparison to the international
elite. It examines the performance and progress in six different areas: number of products, revenue, number of companies,
employment, public investments, and private investments. The basis for this Outlook is a comprehensive database of
information collected at company level. The seven clusters that the Netherlands is compared to are: Boston area, San Diego
area, Research Triangle Park area (USA), United Kingdom, Switzerland, Medicon Valley (Sweden and Denmark) and the
Munich area.
The Decision Group & The Dutch Life Sciences Outlook
The Decision Group is a strategic consulting firm, focussing on: ‘helping our clients to take
better business decisions’. Our advice is pragmatic and involved. As an innovative, high end
strategy consulting firm we have strong academic links with international renowned
universities such as the Harvard Business School, Erasmus Universiteit Rotterdam, The George
Washington University and Universitat St Gallen.
The Decision Group offers different approaches to help taking better decisions. A few examples: cluster and association
management, strategic agenda setting, developing scenarios and scenario planning, creating strategic dialogs between
stakeholders, policy studies and monitors, conjoint analysis and other analytical tools.
The Decision Group
Contact
www.lifesciencesoutlook.com
Dutch Life Sciences Outlook 2014
-Since 2009-
The Decision Group
-Developer-
-The Fifth Edition-
The Dutch Life Sciences Outlook is created under supervision of
Prof. Dr. Fred van Eenennaam and Ir. Maarten Koomans.
It is supported by the International Academic Advisory Council.
Authors
Kim Brüheim, MSc
Bogdan Toma, BSc
Prof. dr. Fred van Eenennaam
Ir. Maarten Koomans
Monitoring & Advising
The cluster is at a crossroads
Visiting address:
Straatweg 130a
3621 BV Breukelen
The Netherlands
T: +31 (0)346 57 49 42
Email: [email protected]
www.thedecisiongroup.nl
-Academic partners-Partners-

Vergelijkbare documenten